Should You Sell Your Affirm Stock?

Should You Sell Your Affirm Stock?

MoneyWeek – All
MoneyWeek – AllFeb 2, 2026

Companies Mentioned

Why It Matters

Affirm’s financial fragility and regulatory risk could trigger a sharp price correction, impacting investors and the broader BNPL market.

Key Takeaways

  • Affirm relies heavily on high‑interest loan revenue.
  • BNPL sector faces potential regulatory scrutiny.
  • Leverage and risky consumer base increase default risk.
  • Valuation multiples remain extremely high despite slowdown.
  • Stock price below 50‑day moving average, short‑sell suggestion.

Pulse Analysis

The buy‑now‑pay‑later (BNPL) market has surged in the past five years, offering consumers flexible financing while providing merchants with higher conversion rates. Yet the rapid expansion has attracted scrutiny from policymakers who argue that BNPL products resemble high‑cost credit. Recent political proposals to cap credit‑card interest rates have amplified concerns that regulators may broaden oversight to include all short‑term consumer loans, placing firms like Affirm in the crosshairs of potential new legislation.

Affirm distinguishes itself by leaning heavily on interest income rather than merchant fees, capturing roughly 75% of its revenue from borrowers paying rates that often exceed 30%. This model amplifies earnings when credit quality remains strong but also magnifies exposure to defaults when economic conditions weaken. The company’s balance sheet shows elevated leverage, and its loan portfolio skews toward higher‑risk consumers, factors that could exacerbate loss rates if unemployment rises or consumer spending contracts. Compared with rivals that diversify revenue streams, Affirm’s concentration on high‑interest loans makes it particularly vulnerable to both macroeconomic headwinds and any regulatory caps on permissible rates.

Investors have responded to these risks with a sharp correction in the stock price, which now sits below its 50‑day moving average despite a two‑year rally. Valuation metrics remain lofty—over 150 times trailing earnings and nearly 45 times projected 2027 earnings—suggesting that the market’s optimism may be overstated. Analysts are recommending short positions at current levels, citing the confluence of aggressive lending practices, regulatory uncertainty, and unsustainable multiples as catalysts for a potential downside move, a scenario that could reverberate across the broader BNPL sector.

Should you sell your Affirm stock?

Comments

Want to join the conversation?

Loading comments...